162 related articles for article (PubMed ID: 34665859)
21. The association of lncRNA SNPs and SNPs-environment interactions based on GWAS with HBV-related HCC risk and progression.
Liu Q; Liu G; Lin Z; Lin Z; Tian N; Lin X; Tan J; Huang B; Ji X; Pi L; Yu X; Liu L; Gao Y
Mol Genet Genomic Med; 2021 Feb; 9(2):e1585. PubMed ID: 33432784
[TBL] [Abstract][Full Text] [Related]
22. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
23. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
24. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both
Tian J; Lou J; Cai Y; Rao M; Lu Z; Zhu Y; Zou D; Peng X; Wang H; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Cancer Res; 2020 May; 80(9):1804-1818. PubMed ID: 32127356
[TBL] [Abstract][Full Text] [Related]
25. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
[TBL] [Abstract][Full Text] [Related]
26. The long noncoding RNA
Pan W; Zhang N; Liu W; Liu J; Zhou L; Liu Y; Yang M
J Biol Chem; 2018 Nov; 293(44):17154-17165. PubMed ID: 30228180
[TBL] [Abstract][Full Text] [Related]
27. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
[TBL] [Abstract][Full Text] [Related]
32. lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability.
Ma Y; Sun W; Zhang Q; Gao B; Cai W; Liu Q; Liao J; Wang X
Biochem Biophys Res Commun; 2021 Aug; 566():101-107. PubMed ID: 34119821
[TBL] [Abstract][Full Text] [Related]
33. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
34. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
35. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Wei C; Wang H; Xu F; Liu Z; Jiang R
Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
[TBL] [Abstract][Full Text] [Related]
36. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
37. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
[TBL] [Abstract][Full Text] [Related]
38. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA.
Bo C; Li X; He L; Zhang S; Li N; An Y
Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528
[TBL] [Abstract][Full Text] [Related]
39. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
[TBL] [Abstract][Full Text] [Related]
40. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
